Evidence Library

Filter by drug, type, year, and open access.

Drug

Type

Year ≥

Sort

Open access

Active filters:Drug: pimavanserin ×Clear filters

Showing 1–3 of 3 results

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus — CNS Spectrums (2018)• Drug: pimavanserinPMID
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis — The Annals of Pharmacotherapy (2017)• Drug: pimavanserinPMID
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial — Lancet (2014)• Drug: pimavanserinPMID

PsychMed Evidence Library — Guidelines, Trials, Meta-Analyses